Published in Blood Weekly, December 7th, 2000
The results were presented during the American Heart Association 73rd Scientific Sessions, held in New Orleans, during November 2000.
The MIRF (Myocardial Ischemia Rating Function) Trial was a double-blinded study of over 300 patients designed to test the utility of measuring serum sphingolipids (a type of lipids in the blood) as predictors of CAD...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.